Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boswellia dalzielii extract is a botanical substance derived from the West African frankincense tree, primarily found in regions like Nigeria and Cameroon. It is being investigated for its neuroprotective, anti-inflammatory, and antioxidant properties, particularly in the context of neurodegenerative disorders. Preclinical research indicates that the extract can mitigate neurological damage in models of Parkinson's disease by reducing oxidative stress in the striatum and midbrain and improving motor deficits. The therapeutic potential of the extract is largely attributed to its high content of bioactive compounds, including boswellic acids and terpenes, which are known to modulate inflammatory pathways and protect dopaminergic neurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boswellia dalzielii extract.